Target Name: NDUFA4
NCBI ID: G4697
Review Report on NDUFA4 Target / Biomarker Content of Review Report on NDUFA4 Target / Biomarker
NDUFA4
Other Name(s): FLJ27440 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4, 9kDa | NADH-ubiquinone oxidoreductase MLRQ subunit | mitochondrial respiratory chain associated factor 1 | CI-MLRQ | COXFA4 | MGC104422 | MISTR1 | Complex I-MLRQ | mitochondrial stress response 1 | MLRQ | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4 | NDUFA4 mitochondrial complex associated | CI-9k | Complex I 9kDa subunit | MGC126845 | Cytochrome c oxidase subunit NDUFA4 | complex I-MLRQ | MGC126843 | MC4DN21 | MRCAF1 | NDUA4_HUMAN | cytochrome c oxidase subunit FA4

NDUFA4's Role in Cell-Cell Adhesion, Signaling Pathways and Pain Perception

NDUFA4 (FLJ27440) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the N-cadherin gene family, which is known for its role in cell-cell adhesion.

The N-cadherin gene family has been implicated in the development and progression of many diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. The encoded protein, NDUFA4, has been shown to play a role in several of these conditions.

One of the main functions of NDUFA4 is its role in cell-cell adhesion. This protein helps to maintain the integrity of the blood-brain barrier, which is responsible for controlling the movement of substances into and out of the brain.NDUFA4 is also involved in the regulation of cell signaling pathways, which are important for many cellular processes.

In addition to its role in cell-cell adhesion and signaling pathways, NDUFA4 is also implicated in the development and progression of several diseases. For example, studies have shown that NDUFA4 is overexpressed in the brains of individuals with Alzheimer's disease, a progressive neurodegenerative disorder.

Furthermore,NDUFA4 has also been shown to be involved in the regulation of pain perception. Studies have shown that NDUFA4 is involved in the production of pain signals in the brain, which can help to contribute to the development of chronic pain conditions.

In conclusion, NDUFA4 is a protein that has been shown to play a role in a variety of conditions, including cell-cell adhesion, signaling pathways, and the regulation of pain perception. Further research is needed to fully understand the role of NDUFA4 in these conditions and to develop effective treatments.

Protein Name: NDUFA4 Mitochondrial Complex Associated

Functions: Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over the inner membrane that drives transmembrane transport and the ATP synthase. Cytochrome c oxidase is the component of the respiratory chain that catalyzes the reduction of oxygen to water. Electrons originating from reduced cytochrome c in the intermembrane space (IMS) are transferred via the dinuclear copper A center (CU(A)) of subunit 2 and heme A of subunit 1 to the active site in subunit 1, a binuclear center (BNC) formed by heme A3 and copper B (CU(B)). The BNC reduces molecular oxygen to 2 water molecules unsing 4 electrons from cytochrome c in the IMS and 4 protons from the mitochondrial matrix (PubMed:22902835). NDUFA4 is required for complex IV maintenance (PubMed:22902835)

The "NDUFA4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NDUFA4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NDUFA4L2 | NDUFA5 | NDUFA5P11 | NDUFA6 | NDUFA6-DT | NDUFA7 | NDUFA8 | NDUFA9 | NDUFAB1 | NDUFAF1 | NDUFAF2 | NDUFAF3 | NDUFAF4 | NDUFAF4P1 | NDUFAF5 | NDUFAF6 | NDUFAF7 | NDUFAF8 | NDUFB1 | NDUFB10 | NDUFB11 | NDUFB2 | NDUFB2-AS1 | NDUFB3 | NDUFB4 | NDUFB5 | NDUFB6 | NDUFB7 | NDUFB8 | NDUFB9 | NDUFC1 | NDUFC2 | NDUFC2-KCTD14 | NDUFS1 | NDUFS2 | NDUFS3 | NDUFS4 | NDUFS5 | NDUFS6 | NDUFS7 | NDUFS8 | NDUFV1 | NDUFV2 | NDUFV2P1 | NDUFV3 | NEAT1 | NEB | NEBL | NECAB1 | NECAB2 | NECAB3 | NECAP1 | NECAP2 | NECTIN1 | NECTIN2 | NECTIN3 | NECTIN3-AS1 | NECTIN4 | NEDD1 | NEDD4 | NEDD4L | NEDD8 | NEDD8-activating enzyme E1 | NEDD8-MDP1 | NEDD9 | NEFH | NEFHP1 | NEFL | NEFM | NEGR1 | NEGR1-IT1 | NEIL1 | NEIL2 | NEIL3 | NEK1 | NEK10 | NEK11 | NEK2 | NEK2-DT | NEK3 | NEK4 | NEK5 | NEK6 | NEK7 | NEK8 | NEK9 | NELF Complex | NELFA | NELFB | NELFCD | NELFE | NELL1 | NELL2 | NEMF | NEMP1 | NEMP2 | NEMP2-DT | NENF | NEO1 | NEPRO